News & Updates

Comorbidities Increase Likelihood of Severe Maternal Morbidity IMI Finds in New Study


October 16, 2020



Comorbidities Increase Likelihood of Severe Maternal Morbidity IMI Finds in New Study

Washington, DC – Did you know that womxn with greater numbers of comorbidities have an increased likelihood of severe maternal morbidity (SMM)? A recent study led by the IMI team and published today in the journal, Obstetrics & Gynecology, found that womxn with one, two, or three or more comorbidities had rates of severe maternal morbidity (SMM) that were 4.9, 7.8, and 11.5 times the rates of SMM compared to womxn who had zero comorbidities. While 67% of White womxn, 68% of Hispanic womxn, and 72% of Asian womxn had zero comorbidities, only 55% of Black womxn had zero comorbidities. Black womxn are around twice as likely to experience SMM.

The new study “Associations Between Comorbidities and Severe Maternal Morbidity,” evaluated rates of SMM during delivery hospitalizations using the National Inpatient Sample, Healthcare Cost and Utilization Project, years 2016-2017. It examined the rates of SMM in womxn in relation to the prevalence of comorbidities. Given the consistently higher rates of SMM among Black womxn compared to White womxn, understanding ways to address structural racism to reduce this disparity is critical for ensuring health equity. 

Access and read the full study here.

 

About the Institute for Medicaid Innovation

The Institute for Medicaid Innovation (IMI) is a 501(c)3 nonprofit, nonpartisan research and policy organization that provides independent, nonpartisan information and analysis to inform Medicaid policy and improve the health of the nation.

 

Media Contact

Lydia Tonkonow

ltonkonow@medicaidinnovation.org